12/19/2025 | Press release | Distributed by Public on 12/19/2025 13:06
NATIONWIDE VARIABLE INSURANCE TRUST
NVIT J.P. Morgan Equity and Options Total Return Fund (formerly, NVIT AQR Large Cap Defensive Style Fund)
Supplement dated December 19, 2025
to the Summary Prospectus dated April 30, 2025
Capitalized terms and certain other terms used in this supplement, unless otherwise defined in this supplement, have the meanings assigned to them in the Summary Prospectus.
Effective immediately, the Summary Prospectus is amended as follows:
| 1. |
The section entitled "Performance" on page 4 of the Summary Prospectus is supplemented to include the following: |
The Fund's performance prior to September 22, 2025 reflects returns pursuant to a different subadviser. If the Fund's current subadviser had been in place for the prior periods, the performance information shown would have been different.
| 2. |
The third sentence in the first paragraph under the section entitled "Performance" on page 4 of the Summary Prospectus is deleted in its entirety and replaced with the following: |
The table shows the Fund's average annual total returns for certain time periods compared to the returns of a broad-based securities market index and an additional index. The additional index has characteristics relevant to the Fund's investment strategy.
| 3. |
The table under the section entitled "Performance - Average Annual Total Returns (For the Periods Ended December 31, 2024)" on page 4 of the Summary Prospectus is deleted in its entirety and replaced with the following: |
| 1 Year | 5 Years | 10 Years | ||||||
|
Class I Shares |
13.66% | 8.67% | 10.26% | |||||
|
Class II Shares |
13.33% | 8.39% | 9.99% | |||||
|
Class IV Shares |
13.67% | 8.67% | 10.26% | |||||
|
Class Y Shares |
13.66% | 8.67% | 10.25% | |||||
|
S&P 500® Index (reflects no deduction for fees or expenses) |
25.02% | 14.53% | 13.10% | |||||
|
ICE BofA Merrill Lynch 3 Month U.S. Treasury Bill Index (reflects no deduction for fees or expenses) |
5.29% | 2.48% | 1.75% | |||||
PLEASE RETAIN THIS SUPPLEMENT FOR FUTURE REFERENCE